VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 356 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2016. The put-call ratio across all filers is 1.00 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $581,000 | -12.6% | 25,000 | -40.1% | 0.28% | +80.3% |
| Q1 2018 | $665,000 | -4.5% | 41,750 | +24.6% | 0.16% | -0.6% |
| Q4 2017 | $696,000 | -59.8% | 33,500 | -66.5% | 0.16% | -70.5% |
| Q2 2017 | $1,730,000 | +526.8% | 100,000 | +300.0% | 0.54% | +654.9% |
| Q1 2017 | $276,000 | -95.5% | 25,000 | -94.1% | 0.07% | -97.5% |
| Q4 2016 | $6,171,000 | +1431.3% | 425,000 | +2025.0% | 2.88% | +1467.4% |
| Q2 2016 | $403,000 | -52.1% | 20,000 | -37.5% | 0.18% | -4.2% |
| Q1 2016 | $842,000 | -83.4% | 32,000 | -36.0% | 0.19% | -88.2% |
| Q4 2015 | $5,083,000 | +2035.7% | 50,000 | +4559.8% | 1.63% | +3975.0% |
| Q2 2015 | $238,000 | – | 1,073 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chou Associates Management | 1,648,992 | $38,323,000 | 14.52% |
| Paulson & Co. | 20,839,035 | $484,299,000 | 9.89% |
| MILLER VALUE PARTNERS, LLC | 4,999,064 | $116,178,000 | 4.34% |
| GoldenTree Asset Management | 1,140,205 | $26,498,000 | 4.21% |
| Pomelo Capital LLC | 1,760,000 | $40,902,000 | 4.00% |
| Bruce & Co., Inc. | 860,000 | $19,986,000 | 3.98% |
| ValueAct Holdings | 18,033,149 | $419,090,000 | 3.79% |
| Stanley Capital Management, LLC | 318,400 | $7,400,000 | 3.25% |
| Kazazian Asset Management, LLC | 134,784 | $3,132,000 | 2.87% |
| Phoenix Investment Adviser LLC | 58,400 | $1,357,000 | 2.48% |